Berapakah harga OncoCyte Corporation (OCX)

Harga OncoCyte Corporation (OCX) adalah $2.84

Apakah topi pasaran OncoCyte Corporation (OCX)

Cap pasaran OncoCyte Corporation (OCX) adalah $729.71K

OncoCyte Corporation (OCX) Pecahan Saham

OncoCyte Corporation is a molecular diagnostics firm that conceptualizes, refines, and brings to market its exclusive laboratory-developed tests aimed at identifying cancer in patients, serving both the United States and global markets. The company's portfolio features DetermaRx, a specialized molecular test for detecting early-stage adenocarcinoma in the lung, alongside DetermaIO, a unique proprietary assay that assesses gene expression. In addition to its diagnostic offerings, OncoCyte provides a suite of services including biomarker discovery, the design and development of new assays, and essential support for clinical trials. It also delivers various biomarker testing solutions specifically tailored for pharmaceutical companies. OncoCyte has established a collaborative agreement with Life Technologies Corporation. This partnership is geared towards the co-development and commercialization of the Oncomine Comprehensive Assay Plus and Determa IO assay, which are designed for use with the Ion Torrent Genexus integrated sequencer and purification system. The corporation was founded in 2009 and its primary base of operations is situated in Irvine, California.

Tahun	Pecahan	Gandaan	Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.

Tahun

Pecahan

Gandaan

Gandaan Kumulatif

Tidak cukup data untuk tarikh yang disediakan.

Syarikat	Bilangan pecahan saham	Gandaan Kumulatif	Negara
Vertex Pharmaceuticals Incorporated VRTX.US	1	x2	US
Argenx SE ARGX.US	0	-	NL
Lonza Group AG LONN.SW	0	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	0	-	KR
UCB S.A. UCB.BR	0	-	BE

Syarikat

Bilangan pecahan saham

Gandaan Kumulatif

Negara